Pacira BioSciences, Inc. (PCRX) vs Vor Biopharma Inc. (VOR)
A side-by-side comparison of Pacira BioSciences, Inc. and Vor Biopharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PCRX
Pacira BioSciences, Inc.
$24.76HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VOR
Vor Biopharma Inc.
$18.31HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — PCRX vs VOR
growth of $100 · dividends reinvested · last 6yPCRX -65.0% (-16.0%/yr)VOR -97.5% (-46.0%/yr)PCRX compounded faster over this window
Log scale — wide-divergence pair
PCRX VOR
PCRX vs VOR: by the numbers
- •VOR is the larger company ($992M vs $974M market cap).
- •PCRX is profitable (1.96% net margin) while VOR runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | PCRX | VOR |
|---|---|---|
| P/E ratio | 70.48 | N/A |
| P/S ratio | 1.31 | N/A |
| P/B ratio | 1.45 | N/A |
| EV / EBITDA | 11.39 | N/A |
| FCF yield | 18.43% | N/A |
Profitability
| Metric | PCRX | VOR |
|---|---|---|
| Gross margin | 79.21% | 0.00% |
| Operating margin | 2.47% | 0.00% |
| Net margin | 1.96% | 0.00% |
| ROE | 2.18% | N/A |
| ROIC | 1.35% | -32.24% |
Growth (annualized)
| Metric | PCRX | VOR |
|---|---|---|
| Revenue CAGR (5Y) | 8.20% | N/A |
| EPS CAGR (5Y) | -45.77% | N/A |
| FCF CAGR (5Y) | 16.72% | N/A |
| Total return CAGR (5Y) | -12.27% | -42.54% |
Frequently asked
- Is PCRX or VOR more profitable?
- PCRX runs the higher net margin — PCRX at 1.96% versus VOR at 0.00%.
- How have PCRX and VOR total returns compared?
- Over the past 5 years, PCRX delivered -12.27% and VOR delivered -42.54% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Pacira BioSciences P/E ratioPacira BioSciences ROEVor Biopharma ROEPacira BioSciences operating marginVor Biopharma operating marginPacira BioSciences revenue growthVor Biopharma revenue growthPacira BioSciences free cash flowVor Biopharma free cash flow
Pacira BioSciences & Vor Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.